[ad_1]
A 13-minute section on a current episode of CBS’s 60 Minutes seemed to be a information story on Novo Nordisk’s weight-loss drug Wegovy, however was really a sponsored promotion violating federal rules, in accordance with the nonprofit public well being advocacy group Physicians Committee.
The group filed a grievance with the Meals and Drug Administration final week, arguing that the section, which aired on January 1, violates the FDA’s “honest stability” requirement. This regulation requires that drug commercials give a good stability to a drug’s dangers and advantages.
The Physicians Committee claims that CBS’s 60 Minutes obtained promoting funds from Novo Nordisk previous to the protection, and that the aired section solely included specialists who had additionally been paid by Novo Nordisk. The section lauded the drug with phrases and phrases comparable to “extremely efficient,” “secure,” “spectacular,” “fabulous,” and “strong,” however did not delve into unwanted effects or different therapies and techniques for weight reduction.
“The 60 Minutes program appeared like a information story, however it was successfully a drug advert,” Physicians Committee President Neal Barnard, adjunct professor of medication at George Washington College College of Drugs, mentioned in an announcement. He famous that Wegovy has a spread of potential dangers and unwanted effects that went unmentioned in CBS’s protection, comparable to digestive issues, elevated coronary heart charge, gallstones, pancreatitis, and severe drops in blood sugar. The drug additionally poses dangers for people who find themselves pregnant or might turn into pregnant.
The group is in search of to have all of CBS’s Wegovy-related tales—there are 4—pulled from its web sites and a “corrective advert” that incorporates dangers and unwanted effects put up of their place.
In an announcement to media retailers, Novo Nordisk mentioned:
Novo Nordisk didn’t present any fee or sponsorship to CBS 60 Minutes for his or her reporting on weight problems as a part of a information section that aired on January 1, 2023, and we didn’t management any of the content material or have any function in figuring out or deciding on the medical doctors and sufferers featured within the information section.
[ad_2]
